Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study
Tóm tắt
Acromegaly is characterized by a broad range of manifestations. Early diagnosis is key to treatment success, but is often delayed as symptomatology overlaps with common disorders. We investigated sign-and-symptom associations, demographics, and clinical characteristics at acromegaly diagnosis. Observational, cross-sectional, multicenter non-interventional study conducted at 25 hospital departments in France that treat acromegaly (ClinicalTrials.gov: NCT02012127). Adults diagnosed with acromegaly < 5 years were enrolled. Demographic and clinical data were obtained from medical reports and patient questionnaires. Sign-and-symptom associations were assessed by multiple correspondence analysis (MCA). Overall, 472 patients were included in the analyses. MCA was unsuccessful in identifying sign-and-symptom associations at diagnosis. Endocrinologists (29.5% patients) and other clinical specialists (37.2% patients) were commonly first to suspect acromegaly. Morphologic manifestations (83.7–87.9% patients), snoring syndrome (81.4% patients), and asthenia (79.2% patients) were frequently present at diagnosis; differences were found between sexes for specific manifestations. Rates of discrepancy between patient- and physician-reported manifestations were highest for functional signs. Earliest manifestations prior to diagnosis, according to how they were detected, were enlarged hands and feet (6.4 ± 6.8 and 6.2 ± 6.9 years, functional signs), hypertension (6.6 ± 7.5 years, complementary examination) and carpal/cubital tunnel syndrome (5.7 ± 6.7 years, functional signs with complementary examination). Results confirm the broad range of manifestations at diagnosis and delay in recognizing the disease. We identified early manifestations and sex differences that may aid physicians in diagnosing acromegaly. Discrepancy rates suggest physicians should obtain the patient’s perspective and seek functional signs during diagnosis.
Tài liệu tham khảo
I.M. Holdaway, C. Rajasoorya, Epidemiology of acromegaly. Pituitary 2, 29–41 (1999)
G. Lugo, L. Pena, F. Cordido, Clinical manifestations and diagnosis of acromegaly. Int. J. Endocrinol. 2012, 540398 (2012)
P. Chanson, S. Salenave, P. Kamenicky, Acromegaly. Handb. Clin. Neurol. 124, 197–219 (2014)
C. Capatina, J.A. Wass, 60 years of neuroendocrinology: acromegaly. J. Endocrinol. 226, T141–T160 (2015)
O.M. Dekkers, N.R. Biermasz, A.M. Pereira, J.A. Romijn, J.P. Vandenbroucke, Mortality in acromegaly: a metaanalysis. J. Clin. Endocrinol. Metab. 93, 61–67 (2008)
I.M. Holdaway, M.J. Bolland, G.D. Gamble, A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur. J. Endocrinol. 159, 89–95 (2008)
D.R. Clemmons, K. Chihara, P.U. Freda, K.K. Ho, A. Klibanski, S. Melmed, S.M. Shalet, C.J. Strasburger, P.J. Trainer, M.O. Thorner, Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J. Clin. Endocrinol. Metab. 88, 4759–4767 (2003)
A. Mestron, S.M. Webb, R. Astorga, P. Benito, M. Catala, S. Gaztambide, J.M. Gomez, I. Halperin, T. Lucas-Morante, B. Moreno, G. Obiols, P.P. de, C. Paramo, A. Pico, E. Torres, C. Varela, J.A. Vazquez, J. Zamora, M. Albareda, M. Gilabert, Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur. J. Endocrinol. 151, 439–446 (2004)
D.A. Gordon, F.M. Hill, C. Ezrin, Acromegaly: a review of 100 cases. Can. Med. Assoc. J. 87, 1106–1109 (1962)
L. Alexander, D. Appleton, R. Hall, W.M. Ross, R. Wilkinson, Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. (Oxf.). 12, 71–79 (1980)
J.D. Nabarro, Acromegaly. Clin. Endocrinol. 26, 481–512 (1987)
B.A. Bengtsson, S. Eden, I. Ernest, A. Oden, B. Sjogren, Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984. Acta Med. Scand. 223, 327–335 (1988)
C. Rajasoorya, I.M. Holdaway, P. Wrightson, D.J. Scott, H.K. Ibbertson, Determinants of clinical outcome and survival in acromegaly. Clin. Endocrinol. 41, 95–102 (1994)
L. Nachtigall, A. Delgado, B. Swearingen, H. Lee, R. Zerikly, A. Klibanski, Changing patterns in diagnosis and therapy of acromegaly over two decades. J. Clin. Endocrinol. Metab. 93, 2035–2041 (2008)
I. Kreitschmann-Andermahr, S. Siegel, B. Kleist, J. Kohlmann, D. Starz, R. Buslei, M. Koltowska-Haggstrom, C.J. Strasburger, M. Buchfelder, Diagnosis and management of acromegaly: the patient’s perspective. Pituitary 19, 268–276 (2016)
T.J. Reid, K.D. Post, J.N. Bruce, M. Nabi Kanibir, C.M. Reyes-Vidal, P.U. Freda, Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin. Endocrinol. 72, 203–208 (2010)
D.R. Clemmons, Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin. Chem. 57, 555–559 (2011)
M.H. Gurel, P.R. Bruening, C. Rhodes, K.G. Lomax, Patient perspectives on the impact of acromegaly: results from individual and group interviews. Patient Prefer. Adherence 8, 53–62 (2014)
T. Brue, F. Castinetti, The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet J. Rare Dis. 11, 135 (2016)
L. Maione, T. Brue, A. Beckers, B. Delemer, P. Petrossians, F. Borson-Chazot, O. Chabre, P. Francois, J. Bertherat, C. Cortet-Rudelli, P. Chanson; French Acromegaly Registry, G., Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur. J. Endocrinol. 176, 645–655 (2017)
B.S. Everitt, Multivariate analysis: the need for data, and other problems. Br. J. Psychiatry 126, 237–240 (1975)
A.L. Comfrey, H.B. Lee. A First Course In Factor Analysis. (Lawrence Erlbaum Associates, Hillsdale, NJ, 1992)
A.B. Costello, J.W. Osbourne, Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract. Assess. Res. Eval. 10, 1–9 (2005)
I.C. Sacco, E.Y. Suda, V. Vigneron, C.D. Sartor, , An ‘Importance’ Map of Signs and Symptoms to Classify Diabetic Polyneuropathy: An Exploratory Data Analysis. PLoS One 10, e0129763 2015).
C.K. Porter, M.S. Riddle, A.N. Alcala, D.A. Sack, C. Harro, S. Chakraborty, R.L. Gutierrez, S.J. Savarino, M. Darsley, R. McKenzie, B. DeNearing, H. Steinsland, D.R. Tribble, A.L. Bourgeois, , An evidenced-based scale of disease severity following human challenge with enteroxigenic Escherichia coli. PLoS One 11, e0149358 2016).
N. Sourial, C. Wolfson, B. Zhu, J. Quail, J. Fletcher, S. Karunananthan, K. Bandeen-Roche, F. Beland, H. Bergman, Correspondence analysis is a useful tool to uncover the relationships among categorical variables. J. Clin. Epidemiol. 63, 638–646 (2010)
N. Prencipe, I. Floriani, F. Guaraldi, S.V. Di Giacomo, S. Cannavo, G. Arnaldi, A. Berton, V. Torri, M. Spinello, E. Arvat, E. Ghigo, S. Grottoli, ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. Clin. Endocrinol. 84, 380–385 (2016)
J. Danzig, Acromegaly. BMJ 335, 824–825 (2007)
S. Ezzat, M.J. Forster, P. Berchtold, D.A. Redelmeier, V. Boerlin, A.G. Harris, Acromegaly. Clinical and biochemical features in 500 patients. Medicine 73, 233–240 (1994)
P. Petrossians, A.F. Daly, E. Natchev, L. Maione, K. Blijdorp, M. Sahnoun-Fathallah, R. Auriemma, A.M. Diallo, A.L. Hulting, D. Ferone, V. Hana Jr., S. Filipponi, C. Sievers, C. Nogueira, C. Fajardo-Montanana, D. Carvalho, V. Hana, G.K. Stalla, M.L. Jaffrain-Rea, B. Delemer, A. Colao, T. Brue, S. Neggers, S. Zacharieva, P. Chanson, A. Beckers, Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database. Endocr. Relat. Cancer 24, 505–518 (2017)
S. Tanaka, I. Fukuda, N. Hizuka, K. Takano, Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly. Endocr. J. 57, 477–483 (2010)